Crispr Therapeutics shares owned by Millennium Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Millennium Management
from 13F filings
Historical chart of Millennium Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Millennium Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.6M | 86k | 64.81 |
| 2025-06-30 | $3.4M | 70k | 48.64 |
| 2025-03-31 | $20M | 584k | 34.03 |
| 2024-12-31 | $335k | 8.5k | 39.36 |
| 2024-09-30 | $6.7M | 143k | 46.98 |
| 2024-06-30 | $1.4M | 26k | 54.01 |
| 2024-03-31 | $7.4M | 109k | 68.16 |
| 2023-12-31 | $1.1M | 17k | 62.60 |
| 2023-09-30 | $6.2M | 136k | 45.39 |
| 2023-06-30 | $6.3M | 113k | 56.14 |
| 2023-03-31 | $12M | 260k | 45.23 |
| 2022-12-31 | $494k | 12k | 40.68 |
| 2022-06-30 | $1.2M | 20k | 60.75 |
| 2022-03-31 | $4.2M | 67k | 62.76 |
| 2021-09-30 | $25M | 222k | 111.93 |
| 2021-06-30 | $19M | 120k | 161.89 |
| 2021-03-31 | $16M | 133k | 121.87 |
| 2020-12-31 | $9.5M | 62k | 153.10 |
| 2020-06-30 | $3.3M | 46k | 73.48 |
| 2019-12-31 | $19M | 312k | 60.91 |
| 2019-09-30 | $4.4M | 107k | 40.98 |
| 2018-09-30 | $3.0M | 67k | 44.34 |
| 2017-12-31 | $2.2M | 95k | 23.48 |
| 2017-09-30 | $1.3M | 75k | 17.87 |
| 2017-06-30 | $529k | 33k | 16.03 |
| 2016-12-31 | $241k | 12k | 20.23 |